Renaissance Technologies’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-581,300
| Closed | -$1.08M | – | 4431 |
|
|
2023
Q1 | $1.08M | Buy |
581,300
+304,404
| +110% | +$563K | ﹤0.01% | 2436 |
|
|
2022
Q4 | $307K | Buy |
276,896
+197,196
| +247% | +$219K | ﹤0.01% | 3208 |
|
|
2022
Q3 | $186K | Sell |
79,700
-131,381
| -62% | -$307K | ﹤0.01% | 3409 |
|
|
2022
Q2 | $640K | Buy |
211,081
+192,981
| +1,066% | +$585K | ﹤0.01% | 2999 |
|
|
2022
Q1 | $123K | Buy |
+18,100
| New | +$123K | ﹤0.01% | 3760 |
|
|
2021
Q3 | – | Sell |
-133,300
| Closed | -$906K | – | 3969 |
|
|
2021
Q2 | $906K | Buy |
133,300
+113,990
| +590% | +$775K | ﹤0.01% | 2716 |
|
|
2021
Q1 | $198K | Sell |
19,310
-111,204
| -85% | -$1.14M | ﹤0.01% | 3155 |
|
|
2020
Q4 | $914K | Sell |
130,514
-169,600
| -57% | -$1.19M | ﹤0.01% | 2549 |
|
|
2020
Q3 | $2.45M | Sell |
300,114
-196,500
| -40% | -$1.6M | ﹤0.01% | 2010 |
|
|
2020
Q2 | $3.43M | Sell |
496,614
-203,500
| -29% | -$1.4M | ﹤0.01% | 1859 |
|
|
2020
Q1 | $3.33M | Buy |
700,114
+290,200
| +71% | +$1.38M | ﹤0.01% | 1792 |
|
|
2019
Q4 | $3.58M | Buy |
409,914
+361,006
| +738% | +$3.15M | ﹤0.01% | 2047 |
|
|
2019
Q3 | $163K | Buy |
48,908
+37,308
| +322% | +$124K | ﹤0.01% | 3195 |
|
|
2019
Q2 | $57K | Sell |
11,600
-1,200
| -9% | -$5.9K | ﹤0.01% | 3441 |
|
|
2019
Q1 | $79K | Sell |
12,800
-199,200
| -94% | -$1.23M | ﹤0.01% | 3328 |
|
|
2018
Q4 | $714K | Buy |
212,000
+44,953
| +27% | +$151K | ﹤0.01% | 2723 |
|
|
2018
Q3 | $1.09M | Buy |
+167,047
| New | +$1.09M | ﹤0.01% | 2570 |
|